Practically Significant Method Comparison Protocols for Machine Learning in Small Molecule Drug Discovery
Every drug hunting project needs its own IP strategy but the current purely
Efficient Crystallization of Apo Sirt2 for Small-Molecule Soaking and Structural Analysis of Ligand Interactions
Exploration of structure-activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment linking and active
Summary of the ACSMEDI-EFMC Medicinal Chemistry Frontiers in May 2025 In May, we had
Cheminformatic Analysis of Core-Atom Transformations in Pharmaceutically Relevant Heteroaromatics J. Med. Chem., 2025, 68, 6,
Summary of 8th RSC-BMCS / SCI Symposium on Ion Channels as Therapeutic Targets –
Quantum Chemical Evaluation and QSAR Modeling of N-Nitrosamine Carcinogenicity N-Nitrosamines (compounds containing the R2N-N=O
Summary of BMCS 2nd Conformational Design in Drug Discovery Conference 2025 Monday 3rd March
Discovery of 6‐Fluoro-5-{4-[(5-fluoro-2-methyl-3-oxo-3,4- dihydroquinoxalin-6 yl)methyl]piperazin-1-yl}‐N‐methylpyridine-2- carboxamide (AZD9574): A CNS-Penetrant, PARP1-Selective Inhibitor J. Med. Chem.,
There are two parts to our business – Software and Consulting. Get in touch today to find out how we can help you save time and money.
© 2026 MedChemica • All rights reserved.
MCPairs In Practice: What To Make Next
Join our webinar on 5 Oct at 3-4pm BST
41 Avada Avenue, Florida, 98765
403-904-3623
